Cargando…
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
BACKGROUND: Tenosynovial giant cell tumor (TGCT), a rare, locally aggressive neoplasm of the synovium of joints and tendon sheaths, is associated with joint destruction, pain and swelling. Impacts on physical function (PF) vary depending on tumor size and location. The aim of this study was to ident...
Autores principales: | Gelhorn, Heather L., Ye, Xin, Speck, Rebecca M., Tong, Sandra, Healey, John H., Bukata, Susan V., Lackman, Richard D., Murray, Lindsey, Maclaine, Grant, Lenderking, William R., Hsu, Henry H., Lin, Paul S., Tap, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360193/ https://www.ncbi.nlm.nih.gov/pubmed/30714073 http://dx.doi.org/10.1186/s41687-019-0099-0 |
Ejemplares similares
-
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
por: Gelhorn, Heather L., et al.
Publicado: (2016) -
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
por: Bernthal, Nicholas M., et al.
Publicado: (2021) -
Psychometric properties of a custom Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form and worst stiffness numeric rating scale in tenosynovial giant cell tumors
por: Speck, Rebecca M., et al.
Publicado: (2020) -
Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
por: Vaynrub, Anna, et al.
Publicado: (2022) -
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
por: Van De Sande, Michiel, et al.
Publicado: (2021)